National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of 0.5ML Autodisable Syringes manufactured by Afrimedical Manufacturing and Supplies Limited, Ibafo, Ogun ...

Q1 2025 Earnings Call Transcript May 6, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.11, ...

Effective mucosal immunity in the intestine involves a fine balance between tolerance of the microbiome, recognition and elimination of pathogens, and inflammatory tissue injury. The anti-inflammatory ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

Florida may soon be the last state to impose "one-to-one" syringe distribution, rather than the needs-based model recommended ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Biocon Biologics' biosimilar Yesintek is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

In fact, each Revok50 syringe contains 50 mg of HA with a molecular weight of ... and larger aliquots of about 0.1 mL per ...

Wrong lowering for broadcast_to bug Something isn't working needs info More information is required to diagnose & prioritize the issue.